Pharma launch plans often overlook a critical driver of success: a formal insights strategy.
This article based on the Oct 3, 2024 Insights FAWG Forum explores the potential for artificial intelligence (AI) to transform Medical Affairs, focusing on medical insights.
From the Spreadsheet Age to the Age of Generative AI: Where is your organization on the continuum of Insights Management? (And why no one “age” fits the needs of all teams.)
This session will delve into maximizing Medical Affairs’ performance and strategic impact through effective metrics and innovative approaches.
The MAPS Puerto Rico Roundtable hosted by Real Chemistry in March 2024 discussed the integration of digital platforms, AI, and personalized content to enhance engagement with healthcare providers (HCPs). The panel emphasized the shift towards real-time, tailored information delivery and the importance of leveraging insights from both traditional and digital sources to support effective engagement strategies while ensuring compliance.
In this podcast, we explore now that we appreciate the need to demonstrate impact and technologies exist that allow us to measure impact…what’s holding us back?
This webinar explores how we can ensure best practices in journal selection and publication performance.
MEDICAL AFFAIRS: The Roles, Value and Practice of Medical Affairs in the Biopharmaceutical and Medical Technology Industries (Taylor & Francis, 2024)
This Standard and Guidance identifies best practices and recommends guidelines for an effective insights management process.
This podcast reviews new ways of identifying and quantifying opportunities for field medical impact with disease-state analytics.